A decades-long study on ovarian cancer has produced disappointing results, says a British researcher. Following more than 200,000 women for an average of 16 years, the randomized trial found that annual screening for the cancer did not ultimately reduce the number of deaths from the disease. The results were published this week in the journal The Lancet. “Our aim was to try and establish a screening programme for ovarian cancer like we have for cervical and breast cancer,” said Usha Menon, lead investigator of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) and a professor of gynecological cancer at University College London.
More on Ovarian cancer researchers disappointed after trial finds regular screenings fail to reduce deaths via CBC News.